Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply. A new groundbreaking study from the University of Michigan reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV-2 infection in cells.

For the full text version, visit: "Existing drugs kill SARS-CoV-2 in cells."

Don't forget to subscribe and check out all of the shows on the Michigan Medicine Podcast Network.

Hosted on Acast. See acast.com/privacy for more information.